📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors. (2012)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/jm201230z

PubMed Identifier: 22111545

Publication URI: http://europepmc.org/abstract/MED/22111545

Type: Journal Article/Review

Volume: 55

Parent Publication: Journal of medicinal chemistry

Issue: 1

ISSN: 0022-2623